# Innovative Supply Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innovative-supply-solutions

- Industry: Software
- Headquarters: Southampton, US
- Website: www.innovativesupplysolutions.com
- Latest round: Seed (Apr 14, 2010)
- Investors on record: 1

## About

Innovative Supply Solutions, LLC specializes in providing a comprehensive clinical supply platform designed to enhance operational efficiency in clinical trials through data-driven decision-making and real-time management capabilities.Innovative Supply Solutions, LLC focuses on optimizing clinical trials with a robust supply platform. Founded in 2010, the company is headquartered in Southampton, US. The current CEO is Adam Warren, who has a background in clinical supply chain management. The company has engaged in a total of 4 deals, with its most recent deal occurring on February 15, 2018, when it raised an undisclosed amount of venture funding from Ben Franklin Technology Partners.Innovative Supply Solutions (ISS Nexus) offers a comprehensive clinical supply platform that optimizes clinical trials through enhanced operational efficiency and data-driven decision-making. The core product, ISS Nexus, integrates functionalities such as real-time forecasting, inventory management, and trial optimization. Key features include advanced forecasting and trial simulations, real-time temperature-controlled inventory management, and interactive response technology (IRT) with rapid build capabilities. The platform serves pharmaceutical companies, biotech firms, and clinical research organizations (CROs) across North America, Europe, and Asia-Pacific, addressing critical challenges in clinical trial management and supply chain operations.The revenue generation for ISS Nexus is primarily structured around subscription-based models and service agreements with clients in the pharmaceutical and biotechnology sectors. Clients engage with the platform through tiered subscription plans that vary based on the scale of services utilized and the complexity of the trials being managed. These arrangements typically involve long-term partnerships with clients paying recurring fees for access to the clinical supply platform and its associated features. The ISS Nexus product includes various modules that can be tailored to meet specific client needs, ensuring maximum benefit from their investment in the service.Innovative Supply Solutions plans to enhance its product offerings with the launch of new features for the ISS Nexus platform, aimed at improving client experience and functionality in clinical trials. The company is targeting expansion into additional markets in Europe and Asia-Pacific by the end of 2023. The venture funding raised in February 2018 will support these initiatives, facilitating the development of new product features and the expansion into these geographic regions.

## Funding rounds

- Seed, Apr 14, 2010 — BioAdvance

## Investors

- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed